Fitnescity Health

The longevity industry is booming. But marketing can sometimes be louder than science. The last few years gave us an explosion of consumer health tools — biomarker tracking, GLP-1 programs, and body composition monitoring. The demand is real. But in a market moving this fast, the gap between what's marketed and what's clinically defensible has quietly grown. DEXA body composition scanning is a clear example. It is becoming one of the most critical tools in longevity and metabolic health — tracking lean muscle preservation during GLP-1 pharmacotherapy, screening for sarcopenia, and establishing longitudinal baselines that guide long-term decisions. The demand is legitimate. But not all data is equal. A DEXA scan that looks identical on paper can vary significantly based on where it was performed and under what conditions. The hardware inside a DEXA system is highly sensitive to external conditions, calibration drift, and cross-machine variation. A traditional imaging center that carries diagnostic, billing, and malpractice accountability is incentivized to follow hospital-grade quality assurance. But what happens when data is generated by low-cost, high-volume wellness providers? Does clinical integrity still win over commercial realities? In the longevity and enterprise telehealth space, the companies that will define the future of care are the ones asking harder questions about their data thresholds—before their patients have to. Grateful to see this conversation getting the attention it deserves. Thank you, Longevity.Technology, for the coverage. Link to the full article in comments.

We're thrilled to announce our partnership with Zwanger-Pesiri Radiology. For over 70 years, Zwanger-Pesiri has helped set the standard for patient care in New York by combining advanced medical imaging, specialized radiologists, and a deeply patient-centric experience. Through this collaboration, we're proud to bring preventive DEXA and CT Calcium Scoring to Fitnescity Health consumers across 25 new locations throughout Long Island, NY. >> As demand for preventive imaging grows, so does the importance of clinical quality and reproducibility. Low-cost DEXA body composition scans, often performed in non-clinically governed settings, may not provide the reproducible longitudinal data that informed health decisions depend on. Not all DEXA testing environments are created equal, especially for consumers using these scans to make long-term decisions around GLP-1s, longevity, metabolic health, and bone health. That’s why partnerships like this matter. At Fitnescity Health, we believe preventive imaging should be held to a higher standard: medical-grade facilities, experienced imaging teams, physician oversight, and reproducible longitudinal data that consumers and practitioners can actually trust over time. In other words, the Clinical Integrity Standard (CIS) is not just something we talk about. It’s reflected in who we choose to work with. This partnership expands access to preventive health testing across New York and brings us one step closer to our mission: empowering people with the data they need before problems arise. How does Fitnescity Health work? Consumers book their test, receive the required physician approval, access individualized insights, and get a 1:1 MD review, all through Fitnescity Health. A special thank you to Peyton Bowe, MBA and Daniel VanVorst for their partnership in bringing this collaboration to life. We're excited for what’s ahead. Read more about the Clinical Integrity Standard (CIS): https://lnkd.in/ggtmqf64 https://fitnescity.com/cis

GLP-1 medications are changing weight loss at scale, but one question is becoming increasingly important: What kind of weight is actually being lost? That distinction matters. Muscle mass, visceral fat, and bone density are directly linked to long-term metabolic health and physical function. DEXA body composition scanning has become one of the most important tools for understanding what is actually changing during treatment. But longitudinal tracking only matters if the data is reliable and reproducible over time. In this week’s article, I break down why this matters, what consumers should know as low-cost DEXA services expand, and why Fitnescity Health launched the Clinical Integrity Standard for DEXA body composition. I’d love for you to read the full article below, and if it resonates, share it with someone on a GLP-1 journey or working at the intersection of metabolic health and technology.

A normal lab panel does not necessarily mean you are healthy. It means what was measured is within range. What is often not measured is just as important. Muscle, fat distribution, and bone density are directly linked to long-term health, yet they are not part of a standard physical. These are not cosmetic details. They are associated with metabolic health, physical function, and long-term outcomes. Across DEXA scans from 1,000+ test centers, we consistently see differences in muscle, visceral fat, and bone density in individuals with otherwise normal bloodwork. In this week’s article, I break down what routine testing misses and why that is starting to change.